Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Application of phage peptide display technology for the study of food allergen epitopes.

Chen X, Dreskin SC.

Mol Nutr Food Res. 2017 Jun;61(6). doi: 10.1002/mnfr.201600568. Epub 2017 Feb 8. Review.

PMID:
27995755
2.
3.

International Consensus (ICON): allergic reactions to vaccines.

Dreskin SC, Halsey NA, Kelso JM, Wood RA, Hummell DS, Edwards KM, Caubet JC, Engler RJ, Gold MS, Ponvert C, Demoly P, Sanchez-Borges M, Muraro A, Li JT, Rottem M, Rosenwasser LJ.

World Allergy Organ J. 2016 Sep 16;9(1):32. doi: 10.1186/s40413-016-0120-5. eCollection 2016.

4.

Conformational IgE epitopes of peanut allergens Ara h 2 and Ara h 6.

Chen X, Negi SS, Liao S, Gao V, Braun W, Dreskin SC.

Clin Exp Allergy. 2016 Aug;46(8):1120-1128. doi: 10.1111/cea.12764. Epub 2016 Jun 27.

5.

B cells establish, but do not maintain, long-lived murine anti-peanut IgE(a).

Moutsoglou DM, Dreskin SC.

Clin Exp Allergy. 2016 Apr;46(4):640-53. doi: 10.1111/cea.12715.

6.

Gene expression profiles in chronic idiopathic (spontaneous) urticaria.

Patel OP, Giorno RC, Dibbern DA, Andrews KY, Durairaj S, Dreskin SC.

Allergy Rhinol (Providence). 2015 Jan;6(2):101-10. doi: 10.2500/ar.2015.6.0124.

7.

Allergenicity of peanut component Ara h 2: Contribution of conformational versus linear hydroxyproline-containing epitopes.

Bernard H, Guillon B, Drumare MF, Paty E, Dreskin SC, Wal JM, Adel-Patient K, Hazebrouck S.

J Allergy Clin Immunol. 2015 May;135(5):1267-74.e1-8. doi: 10.1016/j.jaci.2014.10.025. Epub 2014 Dec 4.

PMID:
25483599
8.
9.

The potential role of omalizumab in the treatment of chronic urticaria.

Stitt JM, Dreskin SC.

Immunotherapy. 2014;6(6):691-7. doi: 10.2217/imt.14.31.

PMID:
25186602
10.

Vitamin E, γ-tocopherol, diminishes ex vivo basophil response to dust mite allergen.

Mills K, Lay J, Wu W, Robinette C, Kesic MJ, Dreskin SC, Peden DB, Hernandez M.

Allergy. 2014 Apr;69(4):541-4.

11.

Case Title: 45 year-old male with recurrent angioedema: WAO international case-based discussions.

Leiding JW, Beakes D, Dreskin SC, Grumach A, Hide M, Reshef A, Triggiani M, Kaliner MA.

World Allergy Organ J. 2014 Jan 22;7(1):2. doi: 10.1186/1939-4551-7-2. No abstract available.

12.

Fatal case of cephalexin-induced toxic epidermal necrolysis.

Hafermann MJ, Barber GR, Dreskin SC, Lindberg GK.

SAGE Open Med Case Rep. 2014 Apr 17;2:2050313X14532250. doi: 10.1177/2050313X14532250. eCollection 2014.

13.

Ara h 6 complements Ara h 2 as an important marker for IgE reactivity to peanut.

Koid AE, Chapman MD, Hamilton RG, van Ree R, Versteeg SA, Dreskin SC, Koppelman SJ, Wünschmann S.

J Agric Food Chem. 2014 Jan 8;62(1):206-13. doi: 10.1021/jf4022509. Epub 2013 Dec 26.

14.

Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.

Halsey NA, Griffioen M, Dreskin SC, Dekker CL, Wood R, Sharma D, Jones JF, LaRussa PS, Garner J, Berger M, Proveaux T, Vellozzi C; Hypersensitivity Working Group of the Clinical Immunization Safety Assessment Network, Broder K, Setse R, Pahud B, Hrncir D, Choi H, Sparks R, Williams SE, Engler RJ, Gidudu J, Baxter R, Klein N, Edwards K, Cano M, Kelso JM.

Vaccine. 2013 Dec 9;31(51):6107-12. doi: 10.1016/j.vaccine.2013.09.066. Epub 2013 Oct 8.

PMID:
24120547
15.

Urticaria and autoimmunity: where are we now?

Stitt JM, Dreskin SC.

Curr Allergy Asthma Rep. 2013 Oct;13(5):555-62. doi: 10.1007/s11882-013-0366-8. Review.

PMID:
23821106
16.

Implementing standardized intravenous antibiotic desensitizations among hospital inpatients.

Go AC, Barber GR, Dreskin SC.

Am J Health Syst Pharm. 2013 Mar 15;70(6):540-8. doi: 10.2146/ajhp110718.

PMID:
23456408
17.

Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination.

Pahud BA, Williams SE, Dekker CL, Halsey N, Larussa P, Baxter RP, Klein NP, Marchant CD, Sparks RC, Jakob K, Aukes L, Swope S, Barnett E, Lewis P, Berger M, Dreskin SC, Donofrio PD, Sejvar JJ, Slade BA, Gidudu J, Vellozzi C, Edwards KM.

Pediatr Infect Dis J. 2013 Feb;32(2):163-8. doi: 10.1097/INF.0b013e318271b90a.

PMID:
23334340
18.

Ara h 2 and Ara h 6 have similar allergenic activity and are substantially redundant.

Chen X, Wang Q, El-Mezayen R, Zhuang Y, Dreskin SC.

Int Arch Allergy Immunol. 2013;160(3):251-8. doi: 10.1159/000341642. Epub 2012 Oct 16.

19.

Redefining the major peanut allergens.

Zhuang Y, Dreskin SC.

Immunol Res. 2013 Mar;55(1-3):125-34. doi: 10.1007/s12026-012-8355-x. Review.

20.

Expression of recombinant Ara h 6 in Pichia pastoris but not in Escherichia coli preserves allergic effector function and allows assessment of specific mutations.

Zhuang Y, Durrani S, Hodges BD, Dreskin SC, Chen X.

Mol Nutr Food Res. 2012 Jun;56(6):986-95. doi: 10.1002/mnfr.201100827.

PMID:
22707273

Supplemental Content

Loading ...
Support Center